Microsoft (NASDAQ:MSFT | MSFT Price Prediction) at $384.36 looks compelling on the numbers. The stock has fallen 20.17% year to date despite accelerating fundamentals, opening a gap between operating results and price action that is hard to justify on the numbers.
Microsoft runs Intelligent Cloud, Productivity and Business Processes, and More Personal Computing, but the argument centers on Azure and the AI infrastructure feeding it. The company’s AI business is at a $37 billion annual run rate, up 123% year over year, and commercial remaining performance obligations sit at $627 billion, up 99%.
The overhang is capital spending. Q3 FY26 capex hit $30.88 billion, up 84.39%, and management has guided to roughly $190 billion of capex in calendar 2026. That number, sourced from the $190 billion calendar 2026 capex plan, is what the market is choking on.
Why the Capex Surge Is Working
The valuation is not stretched given the growth. Microsoft trades at a trailing P/E of 23 and forward P/E of 20, with 23.4% quarterly earnings growth and 18.3% revenue growth. Azure grew 40% and Microsoft Cloud pulled $54.5 billion in revenue, up 29%.
Execution proves the capex is producing. Nadella cited a 40% improvement in inference throughput, nearly 20% faster GPU deployment, and the Fairwater data center coming online six weeks ahead of schedule. First-party silicon Maya 200 delivers over 30% improved tokens per dollar. For further reading on which builders are best positioned to monetize this cycle, our AI infrastructure research maps the picks-and-shovels beneficiaries.
The Capex Bill Nobody Wants to Pay
Free cash flow is the pressure point. P/FCF sits at 39.87 with a free cash flow yield of 2.51%, below the 10-year Treasury. Q4 capex is guided over $40 billion, and depreciation from AI hardware will grind against margins for years.
Market skepticism is evident. Across the last five quarters, Microsoft beat every time yet posted an average day-of decline of 1.05%. Q2 FY26 beat by 5.61% and shares still dropped 9.99% after the earnings report. Insider activity across 33 recent transactions is net selling, and Reddit sentiment sits at 33, firmly bearish.
The Case for Patience Before Adding
Prediction markets price modest near-term upside only. Polymarket assigns a 52.5% probability to a $405 July close and just 51% odds that Microsoft outvalues Anthropic plus OpenAI by year-end. That signals “wait.”
A patient investor would want to see FCF stabilize as short-lived assets convert to revenue, Azure hold the 40% line, and the OpenAI relationship settle after the 27% stake restructuring and $250 billion incremental Azure commitment. Any slip compresses the multiple further.
What the Numbers Show
Microsoft trades at $384.36 against a consensus target of $559.93, implying roughly 45.7% upside. Coverage is heavy, with 57 analysts split 13 Strong Buy, 41 Buy, 3 Hold, and zero Sell.
Shares are down 20.17% year to date and 23.05% over the trailing year, while the S&P 500 has traded materially higher over the same window, judging by SPY at $751.71 versus $718.66 at the April filing. The 50-day moving average of $405.31 now sits well below the 200-day at $443.59.
Why $384 Screens Attractively on Microsoft
At $384.36, the setup screens attractively.
The $627 billion commercial backlog functions as a pre-sale of the very capacity being built. Amy Hood noted that roughly two-thirds of capex funds short-lived assets that correlate directly with revenue, with the remainder tied to 15-year monetization. That is a factory outlay funding future revenue.
Appreciation runs through the next three to four prints. As Q4 FY26 lands and calendar 2026 capex normalizes into revenue, operating leverage returns. Microsoft is already compounding at a 33.28% ROE and 21.02% ROIC with a 45.62% operating margin and 53.89x interest coverage. The balance sheet absorbs the buildout without strain.
The thesis breaks if Azure decelerates below 30%, RPO conversion slows, or capex intensity persists without matching AI revenue growth beyond FY27. Watch the Azure growth rate, the AI run rate progression from $37 billion, and any softening in the RPO number.
When a business grows earnings 23% and pre-sells $627 billion of future capacity while shares fall 20%, the mispricing is the opportunity.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks